Global Glycohemoglobin Analyzer Market, By Product Type (Analyzers, Bench-top, Portable, Software), Application (Diabetes, Blood Transfusion), Modality (Single Use Analyzer, Batch Analyzer), End User (Hospital Laboratories, Diagnostic Laboratories, Physician Office, Blood banks, Home care Settings, Others) - Industry Trends and Forecast to 2029.
Glycohemoglobin Analyzer Market Analysis and Size
The rising prevalence of diabetes worldwide is predicted to cause the global market for glycohemoglobin analyzer to expand significantly over the next few years. Diabetes affects millions of people all over the world. Heart attack, stroke, kidney failure, among other significant health issues, can be brought by an elevated blood glucose level. To prevent any health-related issues, diabetics must maintain a healthy blood glucose level. Therefore, glycohemoglobin analyzer prove to help monitor diabetes.
Data Bridge Market Research analyses that the glycohemoglobin analyzer market which is expected to undergo a healthy CAGR during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Glycohemoglobin Analyzer Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Type (Bench-Top, Portable), End-Use (Clinic, Hospitals, Laboratory, Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Abbott (U.S.), Trinity Biotech (Ireland), ARKRAY Inc. (Japan), Siemens (Germany), PTS Diagnostics (U.S.), Tosoh Corporation (Japan), Bio-Rad Laboratories, Inc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Erba Mannheim (Germany), Convergent Technologies (U.S.) and Bayer AG (Germany) |
|
Market Opportunities |
|
Market Definition
Glycohemoglobin analyzers measure the amount of glucose in a patient's red blood cells over the previous few months, allowing doctors to monitor the patient's health. Nowadays new portable glycohemoglobin analyzers are entering the market and are used in point-of-care clinics, doctor's offices, and homecare settings.
Global Glycohemoglobin Analyzer Market Dynamics
Drivers
- Increasing prevalence of diabetes
The genetic inherence and environmental factors, number of people with diabetes is rapidly rising. Globally, the prevalence of diabetes is rising at an exponential rate as a result of changing lifestyles. For instance, 463 million individuals globally, between the ages of 20 and 79, were estimated to have diabetes in 2019, according to the International Diabetes Federation (IDF).
- Increased the application centers for glycohemoglobin analyser
The number of application centres has grown in tandem with the number of users. Previously, glycohemoglobin analyzers were mostly used in hospitals. These analyzers are now being used in a variety of clinics and laboratories. Patients can use portable analyzers at home because they are now available.
The use of glycohemoglobin analyzers in hospitals is expected to rise due to an increase in hospitalizations and increase in the number of diabetic patients. These all applications derive the growth of the market.
Opportunities
- Technological advancements in glycohemoglobin analyzers
The millions of people who have diabetes must keep their blood sugar levels close to normal if they want to stop the progression of the disease's consequences. The glycohemoglobin (GHb) test is a vital instrument for keeping an eye on blood glucose levels. The results of a GHb analysis show how much glucose a patient's red blood cells were exposed to over the course of the preceding two to three months, enabling doctors to identify patterns and adjust therapy as necessary. In the United States, this test is commonly performed on blood samples that have been sent to a laboratory, with written results provided to the physician several days later. This will boost the market.
Restraints/Challenges
- High cost
China and India are the worst affected by diabetes. The lack of knowledge of device handling along with poor penetration of diabetic care devices is expected to hinder the growth of the market.
This glycohemoglobin analyzer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycohemoglobin analyzer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Glycohemoglobin Analyzer Market Scope
The glycohemoglobin analyzer market is segmented on the basis of product type, application, modality and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Analyzers
- Bench-top
- Portable
- Software
Application
- Diabetes
- Blood Transfusion
Modality
- Single Use Analyzer
- Batch Analyzer
End User
- Hospital Laboratories
- Diagnostic Laboratories
- Physician Office
- Blood banks
- Home care Settings
- Others
Glycohemoglobin Analyzer Market Regional Analysis/Insights
The glycohemoglobin analyzer market is analysed and market size insights and trends are provided by country, product type, application, modality and end-user as referenced above.
The countries covered in the glycohemoglobin analyzer market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the glycohemoglobin analyzer market due to the increase in technological advancements and the launch of its inventive testing tools along with the rising geriatric population in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The glycohemoglobin analyzer market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for glycohemoglobin analyzer market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the glycohemoglobin analyzer market. The data is available for historic period 2010-2020.
Competitive Landscape and Glycohemoglobin Analyzer Market Share Analysis
The glycohemoglobin analyzer market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glycohemoglobin analyzer market.
Some of the major players operating in the glycohemoglobin analyzer market are:
- Abbott (U.S.)
- Trinity Biotech (Ireland)
- ARKRAY Inc. (Japan)
- Siemens (Germany)
- PTS Diagnostics (U.S.),
- Tosoh Corporation (Japan)
- Bio-Rad Laboratories, Inc (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Erba Mannheim (Germany)
- Convergent Technologies (U.S.)
- Bayer AG (Germany)
SKU-
